Invivyd, Inc. (Nasdaq: IVVD) today announced a peer-reviewed publication by Invivyd that uses data from the recent CANOPY pivotal clinical trial of Invivyd’s monoclonal antibody pemivibart to predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results